

Declines in heart failure mortality in both people with and without diabetes were less marked than were declines in CHD and cerebrovascular disease mortality in most jurisdictions. Heart failure mortality rate ratios have not decreased. A greater focus on reducing heart failure mortality in people with and without diabetes might be required.
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet